Canopy Growth announces partnership with established Spanish pharmaceutical
Ontario-based Canopy Growth (TSX:WEED), the largest cannabis producer in Canada, and its subsidiary Spektrum Cannabis GmbH of Germany, which distributes cannabis medicine to hundreds of pharmacies in Germany, announced a supply license agreement with Alcaliber, S.A., a leading Spanish international pharmaceutical company. Alcaliber, founded in 1973, does research, development, breeding and cultivation, as well as extraction and purification of opioid-based Narcotic Raw Materials (NRMs) and active Pharmaceutical ingredients (APIs).
The partnership brings Alcaliber’s proven background in using controlled substances to produce plant-based medications to Canopy and Spektrum, plus an established distribution network into the European market. “This gives us the additional resources to aggressively enter the European market (through Spektrum) where federally permitted by law…” said Bruce Linton, Chairman and CEO if Canopy Growth.
From the deal, Alcaliber gets the opportunity to move into the cannabis business. It has been granted a license from Spanish authorities to cultivate, produce and export/import cannabis for medical and scientific purposes. Canopy Growth will grant Alcaliber a license to use some of its strains and seeds at Alcaliber facilities worldwide
Canopy traded up 3.27% on the news today to C$9.48 on volume of over 2 million shares. Canopy stock declined from March to June, when it bottomed at C$6.82. Since then it has risen
39% to its present price.
Source: Canopy Growth press release
Canopy Growth announces partnership with established Spanish pharmaceutical
About Cannin.com: Your Marijuana Stocks Resource
Cannin is your #1 resource for marijuana stocks. Our global team of experts evaluates all emerging marijuana stock investing opportunities. We aggregate hundreds of hours of research and provide tips on the best marijuana stock investments for 2020.
Use Cannin as your resource for:
- Cannabis and hemp investing news
- Featured cannabis and hemp company analysis
- Comprehensive cannabis and hemp stock reports
Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.
Many market analysts expect the legal marijuana industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in marijuana stocks is now.
Are you interested in marijuana stocks like Curaleaf, Trulieve, Aurora Cannabis, or Charlotte’s Web,?
Are you looking to buy stock in marijuana companies for 2020? Interested in emerging penny marijuana stocks? Looking for the best Canadian marijuana stocks to invest in? We can help.
Predict price movements of marijuana stocks several hours in advance with our proprietary algorithmic stock trading software.
- +25% Gains in 2020
- +49.8% Gains in 2019
- 108% Backtested since 2012
We’re so confident you’ll love our algotrading marijuana stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.
Profit from the best marijuana stocks – we’ll show you how at cannin.com.
Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Best Hemp Stocks 2020